Disposition of gamithromycin in plasma, pulmonary epithelial lining fluid, bronchoalveolar cells, and lung tissue in cattle

American Journal of Veterinary Research

Volumn 72, Issue 3, 2011, Pages 326-330

  Giguère, Steeve ^a   Huang, Rose ^b   Malinski, Thomas J ^b   Dorr, Paul M ^b   Tessman, Ronald K ^b   Somerville, Bruce A ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CATTLE; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG HALF LIFE; DRUG TISSUE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG PARENCHYMA; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CATTLE; EPITHELIAL CELLS; FEMALE; LUNG; MACROLIDES; MALE;

ANIMALIA; BOS;

EID: 79952729516     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.72.3.326     Document Type: Article

References (21)

1. Huang RA, Letendre LT, Banav N, et al. Pharmacokinetics of gamithromycin in cattle with comparison of plasma and lung tissue concentrations and plasma antibacterial activity. J Vet Pharmacol Ther 2010;33:227-237.
2. Drusano GL. Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics. Pharmacotherapy 2005;25:150S-158S.
3. Godinho KS. Susceptibility testing of tulathromycin: interpretative breakpoints and susceptibility of field isolates. Vet Microbiol 2008;129:426-432.
4. Modric S, Webb AI, Derendorf H. Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle. J Vet Pharmacol Ther 1998;21:444-452. (Pubitemid 29022750)
5. Shryock TR, White DW, Staples JM, et al. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease. J Vet Diagn Invest 1996;8:337-344. (Pubitemid 126672365)
6. Nowakowski MA, Inskeep PB, Risk JE, et al. Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle. Vet Ther 2004;5:60-74.
7. Schunicht OC, Booker CW, Guichon PT, et al. An evaluation of the relative efficacy of tulathromycin for the treatment of undifferentiated fever in feedlot calves in Nebraska. Can Vet J 2007;48:600-606. (Pubitemid 47034612)
8. Kempf I, Reeve-Johnson L, Gesbert F, et al. Efficacy of tilmicosin in the control of experimental Mycoplasma gallisepticum infection in chickens. Avian Dis 1997;41:802-807. (Pubitemid 28091170)
9. Baldwin DR, Honeybourne D, Wise R. Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob Agents Chemother 1992;36:1171-1175.
10. Conte JE, Golden J, Duncan S, et al. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Antimicrob Agents Chemother 1996;40:1617-1622. (Pubitemid 26227345)
11. Rennard SI, Basset G, Lecossier D, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986;60:532-538. (Pubitemid 16019939)
12. Scorneaux B, Shryock TR. The determination of the cellular volume of avian, porcine and bovine phagocytes and bovine mammary epithelial cells and its relationship to uptake of tilmicosin. J Vet Pharmacol Ther 1999;22:6-12. (Pubitemid 29132270)
13. Nix DE, Goodwin SD, Peloquin CA, et al. Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response. Antimicrob Agents Chemother 1991;35:1953-1959.
14. Baldwin DR, Honeybourne D, Wise R. Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance. Antimicrob Agents Chemother 1992;36:1176-1180.
15. Nix DE, Goodwin SD, Peloquin CA, et al. Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning. Antimicrob Agents Chemother 1991;35:1947-1952.
16. Kiem S, Schentag JJ. Interpretation of antibiotic concentration ratios measured in epithelial lining fluid. Antimicrob Agents Chemother 2008;52:24-36.
17. Fietta A, Merlini C, Gialdroni GG. Inhibition of intracellular growth of Staphylococcus aureus by exposure of infected human monocytes to clarithromycin and azithromycin. J Chemother 1997;9:17-22. (Pubitemid 27127984)
18. Labro MT. Intracellular bioactivity of macrolides. Clin Microbiol Infect 1996;1(suppl 1):S24-S30. (Pubitemid 126682670)
19. Mandell GL, Coleman E. Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils. Antimicrob Agents Chemother 2001;45:1794-1798. (Pubitemid 32466350)
20. Retsema JA, Bergeron JM, Girard D, et al. Preferential concentration of azithromycin in an infected mouse thigh model. J Antimicrob Chemother 1993;31(suppl E):5-16. (Pubitemid 23220183)
21. Maglio D, Capitano B, Banevicius MA, et al. Differential efficacy of clarithromycin in lung versus thigh infection models. Chemotherapy 2004;50:63-66. (Pubitemid 38813014)